Literature DB >> 14973779

X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of rett syndrome.

Juan I Young1, Huda Y Zoghbi.   

Abstract

Rett syndrome (RTT), a neurodevelopmental disorder affecting mostly females, is caused by mutations in the X-linked gene encoding methyl-CpG-binding protein 2 (MeCP2). Although the majority of girls with classic RTT have a random pattern of X-chromosome inactivation (XCI), nonbalanced patterns have been observed in patients carrying mutant MECP2 and, in some cases, account for variability of phenotypic manifestations. We have generated an RTT mouse model that recapitulates all major aspects of the human disease, but we found that females exhibit a high degree of phenotypic variability beyond what is observed in human patients with similar mutations. To evaluate whether XCI influences the phenotypic outcome of Mecp2 mutation in the mouse, we studied the pattern of XCI at the single-cell level in brains of heterozygous females. We found that XCI patterns were unbalanced, favoring expression of the wild-type allele, in most mutant females. It is notable that none of the animals had nonrandom XCI favoring the mutant allele. To explore why the XCI patterns favored expression of the wild-type allele, we studied primary neuronal cultures from Mecp2-mutant mice and found selective survival of neurons in which the wild-type X chromosome was active. Quantitative analysis indicated that fewer phenotypes are observed when a large percentage of neurons have the mutant X chromosome inactivated. The study of neuronal XCI patterns in a large number of female mice carrying a mutant Mecp2 allele highlights the importance of MeCP2 for neuronal viability. These findings also raise the possibility that there are human females who carry mutant MECP2 alleles but are not recognized because their phenotypes are subdued owing to favorable XCI patterns.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14973779      PMCID: PMC1182264          DOI: 10.1086/382228

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  44 in total

1.  Patterns of X chromosome inactivation in the Rett syndrome.

Authors:  H Y Zoghbi; A K Percy; R J Schultz; C Fill
Journal:  Brain Dev       Date:  1990       Impact factor: 1.961

2.  Sexing of mouse preimplantation embryos by detection of Y chromosome-specific sequences using polymerase chain reaction.

Authors:  T Kunieda; M Xian; E Kobayashi; T Imamichi; K Moriwaki; Y Toyoda
Journal:  Biol Reprod       Date:  1992-04       Impact factor: 4.285

3.  Diagnostic criteria for Rett syndrome. The Rett Syndrome Diagnostic Criteria Work Group.

Authors: 
Journal:  Ann Neurol       Date:  1988-04       Impact factor: 10.422

4.  Controlling elements in the mouse X-chromosome. I. Interaction with the X-linked genes.

Authors:  B M Cattanach; C E Pollard; J N Perez
Journal:  Genet Res       Date:  1969-12       Impact factor: 1.588

5.  X-chromosome activity in female mouse embryos heterozygous for Pgk-1 and Searle's translocation, T(X; 16) 16H.

Authors:  A McMahon; M Monk
Journal:  Genet Res       Date:  1983-02       Impact factor: 1.588

6.  Primary non-random X-inactivation caused by controlling elements in the mouse demonstrated at the cellular level.

Authors:  S Rastan
Journal:  Genet Res       Date:  1982-10       Impact factor: 1.588

Review 7.  The X chromosome in development in mouse and man.

Authors:  M Monk
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

8.  Rett syndrome in a 47,XXX patient with a de novo MECP2 mutation.

Authors:  Sara Hammer; Naghmeh Dorrani; Jaana Hartiala; Stuart Stein; N Carolyn Schanen
Journal:  Am J Med Genet A       Date:  2003-10-15       Impact factor: 2.802

9.  A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases.

Authors:  B Hagberg; J Aicardi; K Dias; O Ramos
Journal:  Ann Neurol       Date:  1983-10       Impact factor: 10.422

10.  Survey of MeCP2 in the Rett syndrome and the non-Rett syndrome brain.

Authors:  Dawna Duncan Armstrong; Kimiko Deguchi; Bobbie Antallfy
Journal:  J Child Neurol       Date:  2003-10       Impact factor: 1.987

View more
  54 in total

Review 1.  Complexities of Rett syndrome and MeCP2.

Authors:  Rodney C Samaco; Jeffrey L Neul
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

2.  Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome.

Authors:  Paolo Moretti; Jonathan M Levenson; Fortunato Battaglia; Richard Atkinson; Ryan Teague; Barbara Antalffy; Dawna Armstrong; Ottavio Arancio; J David Sweatt; Huda Y Zoghbi
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

Review 3.  Rett syndrome: clinical review and genetic update.

Authors:  L S Weaving; C J Ellaway; J Gécz; J Christodoulou
Journal:  J Med Genet       Date:  2005-01       Impact factor: 6.318

4.  Progress in human genetics.

Authors:  Sara M Mariani
Journal:  MedGenMed       Date:  2004-12-07

5.  Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation.

Authors:  Hayley Archer; Julie Evans; Helen Leonard; Lyn Colvin; David Ravine; John Christodoulou; Sarah Williamson; Tony Charman; Mark E S Bailey; Julian Sampson; Nicholas de Klerk; Angus Clarke
Journal:  J Med Genet       Date:  2006-08-11       Impact factor: 6.318

6.  MeCP2 is critical within HoxB1-derived tissues of mice for normal lifespan.

Authors:  Christopher S Ward; E Melissa Arvide; Teng-Wei Huang; Jong Yoo; Jeffrey L Noebels; Jeffrey L Neul
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

7.  X Chromosome-Inactivation Patterns in 31 Individuals with PHACE Syndrome.

Authors:  C T Sullivan; S L Christian; J T C Shieh; D Metry; F Blei; A Krol; B A Drolet; I J Frieden; W B Dobyns; D H Siegel
Journal:  Mol Syndromol       Date:  2012-11-16

Review 8.  Experimental models of Rett syndrome based on Mecp2 dysfunction.

Authors:  Gaston Calfa; Alan K Percy; Lucas Pozzo-Miller
Journal:  Exp Biol Med (Maywood)       Date:  2011-01

9.  MeCP2 functions largely cell-autonomously, but also non-cell-autonomously, in neuronal maturation and dendritic arborization of cortical pyramidal neurons.

Authors:  Noriyuki Kishi; Jeffrey D Macklis
Journal:  Exp Neurol       Date:  2009-12-16       Impact factor: 5.330

Review 10.  The role of MeCP2 in brain development and neurodevelopmental disorders.

Authors:  Michael L Gonzales; Janine M LaSalle
Journal:  Curr Psychiatry Rep       Date:  2010-04       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.